Handel Evotec AG - EVT CFD
Føj til favorit- Opsummering
- Historisk Data
- Begivenheder
- Resultatopgørelse
- Saldo
- Cash flow
- Ejerskab
Spænd | 0.085 | ||||||||
Long position, gebyr natten over
Long position overnight fee
Gå til platform | -0.017913% | ||||||||
Short position, gebyr natten over
Short position overnight fee
Gå til platform | -0.004309% | ||||||||
Gebyr natten over, tid | 21:00 (UTC) | ||||||||
Min. handlet mængde | 1 | ||||||||
Valuta | EUR | ||||||||
Margen | 20% | ||||||||
Aktiebørs | Germany | ||||||||
Kommission på handel | 0% |
*Information provided by Capital.com
Evotec SE ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Tidligere luk* | 18.055 |
Åben* | 17.98 |
1-Års Ændring* | -35.73% |
Dagens Spænd* | 17.575 - 17.98 |
52-Ugers Spænd | 14.80-29.71 |
Gennemsnitlig Volumen (10 dage) | 521.93K |
Gennemsnitlig Volumen (3 måneder) | 8.76M |
Market Cap | 3.21B |
P/E-forhold | -100.00K |
Udestående aktier | 176.94M |
Omsætning | 697.83M |
EPS | -1.02 |
Dividend (Udbytte %) | N/A |
Beta | 0.82 |
Næste indtjeningsopgørelse | Mar 28, 2023 |
Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Luk | Change | Change (%) | Åben | High | Low |
---|---|---|---|---|---|---|
Mar 21, 2023 | 18.055 | 0.085 | 0.47% | 17.970 | 18.315 | 17.910 |
Mar 20, 2023 | 17.850 | -0.110 | -0.61% | 17.960 | 18.065 | 17.540 |
Mar 17, 2023 | 18.075 | -0.325 | -1.77% | 18.400 | 18.690 | 17.835 |
Mar 16, 2023 | 18.265 | 0.700 | 3.99% | 17.565 | 18.295 | 17.375 |
Mar 15, 2023 | 17.125 | -0.495 | -2.81% | 17.620 | 17.670 | 16.780 |
Mar 14, 2023 | 17.640 | 0.375 | 2.17% | 17.265 | 17.890 | 17.265 |
Mar 13, 2023 | 17.280 | 0.125 | 0.73% | 17.155 | 17.400 | 16.825 |
Mar 10, 2023 | 17.130 | 0.390 | 2.33% | 16.740 | 17.330 | 16.675 |
Mar 9, 2023 | 17.255 | -0.185 | -1.06% | 17.440 | 17.445 | 17.110 |
Mar 8, 2023 | 17.535 | -0.085 | -0.48% | 17.620 | 17.800 | 17.315 |
Mar 7, 2023 | 17.745 | -0.175 | -0.98% | 17.920 | 18.220 | 17.575 |
Mar 6, 2023 | 17.540 | 0.085 | 0.49% | 17.455 | 17.575 | 17.150 |
Mar 3, 2023 | 17.190 | 0.300 | 1.78% | 16.890 | 17.220 | 16.760 |
Mar 2, 2023 | 16.615 | 0.205 | 1.25% | 16.410 | 16.770 | 16.410 |
Mar 1, 2023 | 16.590 | -0.515 | -3.01% | 17.105 | 17.130 | 16.525 |
Feb 28, 2023 | 16.975 | -0.650 | -3.69% | 17.625 | 17.625 | 16.905 |
Feb 27, 2023 | 17.820 | 0.115 | 0.65% | 17.705 | 17.895 | 17.620 |
Feb 24, 2023 | 17.420 | -0.790 | -4.34% | 18.210 | 18.310 | 17.420 |
Feb 23, 2023 | 18.310 | -0.115 | -0.62% | 18.425 | 18.550 | 18.235 |
Feb 22, 2023 | 18.285 | -0.005 | -0.03% | 18.290 | 18.315 | 17.950 |
Evotec AG Events
Tid (UTC) (UTC) | Land | Begivenhed |
---|---|---|
No events scheduled |
- Årlig
- Pr kvartal
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Total omsætning | 618.034 | 500.924 | 446.437 | 375.405 | 263.765 |
Omsætning | 618.034 | 500.924 | 446.437 | 375.405 | 263.765 |
Kost af omsætning, Total | 466.491 | 375.181 | 313.546 | 263.389 | 181.965 |
Bruttofortjeneste | 151.543 | 125.743 | 132.891 | 112.016 | 81.8 |
Totale Driftsudgifter | 588.901 | 452.368 | 383.843 | 297.942 | 227.038 |
Salgs/Generelle/Admin. Udgifter, Total | 105.445 | 77.205 | 66.546 | 57.012 | 42.383 |
Forskning & Udvikling | 72.2 | 63.945 | 58.432 | 35.619 | 17.614 |
Usædvanlig Udgift (Indkomst) | 12.546 | 3.244 | 11.919 | -11.036 | 1.18 |
Other Operating Expenses, Total | -67.781 | -67.207 | -66.6 | -47.042 | -16.104 |
Driftsindtægter | 29.133 | 48.556 | 62.594 | 77.463 | 36.727 |
Renteindkomst (Udgift), Netto Ikke-Drift | 208.106 | -22.925 | -6.102 | -5.602 | -10.37 |
Andre, Netto | -0.259 | 0.209 | 0.07 | 0.138 | -0.792 |
Netto Indkomst Før Skat | 236.98 | 25.84 | 56.562 | 71.999 | 25.565 |
Netto Indkomst Efter Skat | 215.51 | 6.278 | 37.228 | 84.056 | 23.218 |
Minoritetsrente | 0 | 0 | 0.844 | 0.116 | 0.258 |
Netto Indkomst Før Ekstra Ting | 215.51 | 6.278 | 38.072 | 84.172 | 23.476 |
Netto Indkomst | 215.51 | 6.278 | 38.072 | 84.172 | 23.476 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 215.51 | 6.278 | 38.072 | 84.172 | 23.476 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 215.51 | 6.278 | 38.072 | 84.172 | 23.476 |
Fortyndet Netto Indkomst | 215.51 | 6.278 | 38.072 | 84.172 | 23.476 |
Fortyndet Vægtet Gennemsnit Aktier | 166.406 | 153.752 | 149.726 | 147.482 | 145.01 |
Fortyndet EPS Uden Ekstraordinære Ting | 1.29509 | 0.04083 | 0.25428 | 0.57073 | 0.16189 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | 0 |
Fortyndet Normaliseret EPS | 1.36365 | 0.05455 | 0.30667 | 0.52209 | 0.16928 |
Fortyndelsesændring | 0 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Total omsætning | 164.672 | 187.071 | 159.661 | 138.217 | 133.085 |
Omsætning | 164.672 | 187.071 | 159.661 | 138.217 | 133.085 |
Kost af omsætning, Total | 132.378 | 134.997 | 116.494 | 112.594 | 102.406 |
Bruttofortjeneste | 32.294 | 52.074 | 43.167 | 25.623 | 30.679 |
Totale Driftsudgifter | 164.209 | 179.5 | 146.414 | 136.68 | 126.307 |
Salgs/Generelle/Admin. Udgifter, Total | 31.566 | 34.408 | 24.654 | 25.189 | 21.194 |
Forskning & Udvikling | 18.113 | 18.728 | 18.038 | 16.974 | 18.46 |
Other Operating Expenses, Total | -17.848 | -16.005 | -17.263 | -18.76 | -15.753 |
Driftsindtægter | 0.463 | 7.571 | 13.247 | 1.537 | 6.778 |
Renteindkomst (Udgift), Netto Ikke-Drift | -69.555 | -25.191 | 127.127 | 58.478 | 47.692 |
Andre, Netto | 0.359 | -0.216 | 0.017 | -0.03 | -0.03 |
Netto Indkomst Før Skat | -68.733 | -17.836 | 140.391 | 59.985 | 54.44 |
Netto Indkomst Efter Skat | -73.242 | -31.478 | 134.271 | 60.015 | 52.702 |
Netto Indkomst Før Ekstra Ting | -73.242 | -31.478 | 134.271 | 60.015 | 52.702 |
Netto Indkomst | -73.242 | -31.478 | 134.271 | 60.015 | 52.702 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -73.242 | -31.478 | 134.271 | 60.015 | 52.702 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -73.242 | -31.478 | 134.271 | 60.015 | 52.702 |
Fortyndet Netto Indkomst | -73.242 | -31.478 | 134.271 | 60.015 | 52.702 |
Fortyndet Vægtet Gennemsnit Aktier | 176.703 | 172.677 | 164.525 | 164.33 | 164.088 |
Fortyndet EPS Uden Ekstraordinære Ting | -0.41449 | -0.18229 | 0.81611 | 0.36521 | 0.32118 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | 0 |
Fortyndet Normaliseret EPS | -0.41449 | -0.15454 | 0.84222 | 0.36791 | 0.32118 |
Usædvanlig Udgift (Indkomst) | 7.372 | 4.491 | 0.683 | ||
Minoritetsrente | 0 |
- Årlig
- Pr kvartal
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Totale Nuværende Aktiver | 1100.94 | 658.844 | 469.53 | 249.769 | 177.783 |
Likvider og Kortsigtede Investeringer | 858.498 | 492.634 | 321.662 | 149.879 | 91.947 |
Likvider & Lignende | 699.326 | 422.58 | 277.034 | 109.055 | 67.017 |
Kortsigtede Investeringer | 159.172 | 70.054 | 44.628 | 40.824 | 24.93 |
Totale Tilgodehavender, Netto | 176.754 | 122.221 | 117.844 | 74.772 | 63.624 |
Accounts Receivable - Trade, Net | 150.692 | 91.612 | 93.702 | 58.851 | 56.198 |
Total Inventory | 25.793 | 13.585 | 10.749 | 5.66 | 5.568 |
Prepaid Expenses | 19.21 | 9.258 | 9.166 | 8.451 | 8.6 |
Other Current Assets, Total | 20.685 | 21.146 | 10.109 | 11.007 | 8.044 |
Total Assets | 2235.16 | 1462.34 | 1180.91 | 771.883 | 666.475 |
Property/Plant/Equipment, Total - Net | 484.597 | 337.297 | 239.229 | 90.519 | 76.069 |
Property/Plant/Equipment, Total - Gross | 686.086 | 481.879 | 350.415 | 164.143 | 131.682 |
Accumulated Depreciation, Total | -201.489 | -144.582 | -111.186 | -73.624 | -55.613 |
Goodwill, Net | 257.569 | 247.37 | 255.919 | 220.791 | 220.447 |
Intangibles, Net | 30.851 | 98.036 | 116.994 | 122.989 | 135.033 |
Long Term Investments | 287.009 | 59.021 | 41.252 | 28.99 | 22.141 |
Note Receivable - Long Term | 55.966 | 36.485 | 22.718 | 14.601 | 11.168 |
Other Long Term Assets, Total | 18.229 | 25.284 | 35.27 | 44.224 | 23.834 |
Total Current Liabilities | 324.516 | 208.459 | 178.955 | 196.275 | 242.945 |
Accounts Payable | 72.598 | 42.549 | 31.319 | 31.137 | 26.078 |
Accrued Expenses | 33.983 | 34.728 | 29.174 | 25.67 | 18.351 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 50.609 | 30.008 | 20.731 | 56.919 | 168.468 |
Other Current Liabilities, Total | 167.326 | 101.174 | 97.731 | 82.549 | 30.048 |
Total Liabilities | 857.476 | 737.881 | 703.883 | 347.879 | 335.552 |
Total Long Term Debt | 462.308 | 461.957 | 442.368 | 57.546 | 21.46 |
Long Term Debt | 326.344 | 331.019 | 324.886 | 54.68 | 20.295 |
Capital Lease Obligations | 135.964 | 130.938 | 117.482 | 2.866 | 1.165 |
Deferred Income Tax | 17.688 | 20.399 | 21.199 | 21.517 | 23.692 |
Minority Interest | 0 | 0 | 0 | 0.876 | 0.992 |
Other Liabilities, Total | 52.964 | 47.066 | 61.361 | 71.665 | 46.463 |
Total Equity | 1377.69 | 724.456 | 477.029 | 424.004 | 330.923 |
Common Stock | 176.608 | 163.915 | 150.903 | 149.063 | 147.533 |
Additional Paid-In Capital | 1430.14 | 1030.7 | 786.865 | 783.154 | 778.858 |
Retained Earnings (Accumulated Deficit) | -216.421 | -432.639 | -441.177 | -481.013 | -566.565 |
Unrealized Gain (Loss) | 3.053 | 4.26 | 4.565 | 6.002 | 6.384 |
Other Equity, Total | -15.691 | -41.782 | -24.127 | -33.202 | -35.287 |
Total Liabilities & Shareholders’ Equity | 2235.16 | 1462.34 | 1180.91 | 771.883 | 666.475 |
Total Common Shares Outstanding | 176.358 | 163.665 | 150.653 | 148.813 | 147.283 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Totale Nuværende Aktiver | 1061.51 | 1100.94 | 628.306 | 634.802 | 680.401 |
Likvider og Kortsigtede Investeringer | 855.045 | 858.498 | 427.228 | 459.703 | 470.576 |
Likvider & Lignende | 660.488 | 699.326 | 333.404 | 382.311 | 401.597 |
Kortsigtede Investeringer | 194.557 | 159.172 | 93.824 | 77.392 | 68.979 |
Totale Tilgodehavender, Netto | 134.019 | 176.754 | 136.615 | 116.179 | 154.67 |
Accounts Receivable - Trade, Net | 112.617 | 150.692 | 111.501 | 94.166 | 136.494 |
Total Inventory | 26.076 | 25.793 | 22.519 | 17.254 | 15.237 |
Prepaid Expenses | 46.373 | 39.895 | 41.944 | 41.666 | 39.918 |
Total Assets | 2185.02 | 2235.16 | 1767.85 | 1621.12 | 1580.71 |
Property/Plant/Equipment, Total - Net | 521.357 | 484.597 | 472.825 | 449.474 | 374.93 |
Goodwill, Net | 257.649 | 257.569 | 253.709 | 252.961 | 254.041 |
Intangibles, Net | 29.157 | 30.851 | 33.227 | 35.814 | 95.693 |
Long Term Investments | 236.624 | 287.009 | 303.841 | 175.425 | 108.274 |
Note Receivable - Long Term | 61.595 | 55.966 | 50.376 | 45.371 | 40.836 |
Other Long Term Assets, Total | 17.128 | 18.229 | 25.565 | 27.269 | 26.532 |
Total Current Liabilities | 339.62 | 324.516 | 253.778 | 246.947 | 239.606 |
Accounts Payable | 74.739 | 72.598 | 56.72 | 51.363 | 54.88 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 50.641 | 50.609 | 49.356 | 63.909 | 30.145 |
Other Current Liabilities, Total | 214.24 | 201.309 | 147.702 | 131.675 | 154.581 |
Total Liabilities | 875.162 | 857.476 | 775.17 | 768.542 | 787.661 |
Total Long Term Debt | 467.926 | 462.308 | 451.255 | 448.949 | 486.933 |
Long Term Debt | 326.116 | 326.344 | 317.922 | 318.151 | 353.201 |
Capital Lease Obligations | 141.81 | 135.964 | 133.333 | 130.798 | 133.732 |
Deferred Income Tax | 17.552 | 17.688 | 19.208 | 19.58 | 20.654 |
Other Liabilities, Total | 50.064 | 52.964 | 50.929 | 53.066 | 40.468 |
Total Equity | 1309.86 | 1377.69 | 992.679 | 852.574 | 793.046 |
Common Stock | 176.953 | 176.608 | 165.111 | 164.608 | 164.561 |
Additional Paid-In Capital | 1432.45 | 1430.14 | 1035.44 | 1033.67 | 1032.13 |
Retained Earnings (Accumulated Deficit) | -289.629 | -216.421 | -186.245 | -320.691 | -381.249 |
Other Equity, Total | -9.912 | -15.691 | -21.625 | -29.333 | -22.395 |
Total Liabilities & Shareholders’ Equity | 2185.02 | 2235.16 | 1767.85 | 1621.12 | 1580.71 |
Total Common Shares Outstanding | 176.703 | 176.358 | 164.861 | 164.358 | 164.311 |
Unrealized Gain (Loss) | 3.053 | 4.32 | |||
Minority Interest | 0 |
- Årlig
- Pr kvartal
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Netto indkomst/Startlinje | 215.51 | 6.252 | 37.228 | 84.056 | 23.218 |
Likvider Fra Driftsaktiviteter | 122.237 | 44.721 | 42.216 | 156.24 | 10.828 |
Likvider Fra Driftsaktiviteter | 55.596 | 42.122 | 36.456 | 19.288 | 13.725 |
Amortization | 12.012 | 13.936 | 12.349 | 12.005 | 7.041 |
Deferred Taxes | 5.066 | 7.49 | 6.706 | -26.117 | -6.131 |
Ikke-Likvide Ting | -165.371 | 23.865 | 24.342 | 0.364 | 7.904 |
Cash Taxes Paid | -6.028 | 9.796 | 2.417 | 3.596 | 0.103 |
Likvid Rente Betalt | 5.429 | 3.465 | 4.49 | 2.279 | 0.822 |
Ændringer i Driftskapital | -0.576 | -48.944 | -74.865 | 66.644 | -34.929 |
Likvider fra Investeringsaktiviteter | -243.855 | -155.089 | -86.634 | -39.13 | -269.033 |
Kapitaludgifter | -118.943 | -99.072 | -31.905 | -27.867 | -17.587 |
Andre Investerings-Cash-Flow-Ting, Total | -124.912 | -56.017 | -54.729 | -11.263 | -251.446 |
Likvider fra Financieringsaktiviteter | 398.43 | 246.409 | 211.263 | -77.764 | 240.724 |
Financiering af Cash-Flow-Ting | |||||
Udstedelse (Pensionering) af Aktier, Netto | 404.322 | 251.564 | 1.901 | 1.578 | 92.356 |
Udstedelse (Pensionering) af Gæld, Netto | -5.892 | -5.155 | 209.362 | -79.342 | 148.368 |
Udenlandsk Børs Effekter | -0.066 | 9.505 | 1.134 | 2.692 | 0.558 |
Netto Ændring i Likviditet | 276.746 | 145.546 | 167.979 | 42.038 | -16.923 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -73.242 | 215.51 | 246.988 | 112.717 | 52.702 |
Cash From Operating Activities | 63.618 | 122.237 | 61.902 | 41.105 | 2.459 |
Changes in Working Capital | 136.86 | -93.273 | -185.086 | -71.612 | -50.243 |
Cash From Investing Activities | -95.732 | -243.855 | -146.74 | -96.457 | -46.504 |
Capital Expenditures | -42.921 | -118.943 | -100.183 | -72.573 | -36.297 |
Other Investing Cash Flow Items, Total | -52.811 | -124.912 | -46.557 | -23.884 | -10.207 |
Cash From Financing Activities | -5.279 | 398.43 | -7.148 | 12.457 | 17.931 |
Issuance (Retirement) of Stock, Net | 0.345 | 404.322 | 1.196 | 0.693 | 0.646 |
Issuance (Retirement) of Debt, Net | -5.624 | -5.892 | -8.344 | 11.764 | 17.285 |
Foreign Exchange Effects | -1.445 | -0.066 | 2.81 | 2.626 | 5.131 |
Net Change in Cash | -38.838 | 276.746 | -89.176 | -40.269 | -20.983 |
Investornavn | Investortype | Procent udestående | Aktiebeholdning | Aktieændring | Beholdningsdato | IOmsætningsscore |
---|---|---|---|---|---|---|
T. Rowe Price International Ltd | Investment Advisor/Hedge Fund | 10.0958 | 17888267 | 197835 | 2022-11-10 | MED |
Novo Holdings A/S | Venture Capital | 9.8455 | 17444807 | -206374 | 2022-12-31 | LOW |
Mubadala Investment Company PJSC | Sovereign Wealth Fund | 6.4799 | 11481502 | 2298850 | 2021-11-08 | LOW |
Government of Abu Dhabi | Government Agency | 6.4788 | 11479533 | 1602555 | 2021-12-31 | LOW |
T. Rowe Price Associates, Inc. | Investment Advisor | 5.0138 | 8883666 | -1796 | 2023-01-31 | LOW |
BlackRock Asset Management Deutschland AG | Investment Advisor | 3.671 | 6504551 | -2755 | 2022-06-03 | LOW |
Allianz Global Investors GmbH | Investment Advisor | 2.9667 | 5256528 | -2846371 | 2022-01-07 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.5091 | 4445816 | 7452 | 2023-02-28 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 2.2224 | 3937850 | 851779 | 2022-12-31 | LOW |
Liontrust Investment Partners LLP | Investment Advisor | 2.1651 | 3836320 | -8983 | 2023-01-31 | LOW |
Brown Capital Management, LLC | Investment Advisor | 2.165 | 3836114 | -24213 | 2022-09-30 | LOW |
Oetker (Roland) | Individual Investor | 1.639 | 2904146 | -5440854 | 2022-10-04 | LOW |
Franklin Equity Group | Investment Advisor | 1.4392 | 2550000 | 0 | 2023-02-28 | LOW |
DWS Investment GmbH | Investment Advisor/Hedge Fund | 1.2419 | 2200506 | 7813 | 2023-02-28 | LOW |
California State Teachers Retirement System | Pension Fund | 1.0986 | 1946619 | 1704482 | 2022-06-30 | LOW |
Polar Capital LLP | Investment Advisor/Hedge Fund | 1.0123 | 1793563 | 0 | 2022-12-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.9995 | 1770896 | 17426 | 2023-02-28 | LOW |
Baillie Gifford & Co. | Investment Advisor | 0.8472 | 1501060 | -9797 | 2023-01-31 | LOW |
Lanthaler (Werner) | Individual Investor | 0.8196 | 1452188 | 340452 | 2021-09-30 | LOW |
Evotec SE Management | Corporation | 0.7974 | 1412866 | -233297 | 2021-12-31 | LOW |
Hvorfor vælge Capital.com? Vores tal taler for sig selv.
Capital.com Group500K+
Handlende
92K+
Månedlkige, aktive klienter
$53M+
Månedlig investeringsvolumen
$30M+
Hævet hver måned
Handelslommeregner
Udregn dit hypotetiske P&L hvis du havde åbnet en CFD-handel på en given dato (vælg en dato) og lukket den på en anden dato (vælg en dato).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Evotec Company profile
Om Evotec AG
Evotec SE er en tysk virksomhed, der beskæftiger sig med forskning i og udvikling af lægemidler. Virksomheden beskæftiger sig med udvikling af nye farmaceutiske produkter gennem forskningsalliancer og udviklingspartnerskaber med farmaceutiske og bioteknologiske virksomheder, akademiske institutioner, patientorganisationer og venturekapitalvirksomheder. Løsningerne inden for lægemiddelforskning leveres i form af vederlag for servicearbejde, integrerede alliancer inden for lægemiddelforskning, udviklingspartnerskaber, licensering af lægemiddelkandidater og konsulentordninger. Evotec SE opererer inden for en række områder, herunder neurovidenskab, diabetes og komplikationer til diabetes, smerte og inflammation, onkologi, infektionssygdomme, luftvejssygdomme og fibrose. Virksomhedens pipeline dækker en række terapeutiske områder som f.eks. CNS-søvnløshed, kronisk hoste, immunologi og inflammation, kvindesundhed, endometriose, nefrologi, dermatologiske sygdomme, fibrotiske sygdomme og antivirale sygdomme m.m.
Industry: | Biotechnology & Medical Research (NEC) |
Essener Bogen 7
HAMBURG
HAMBURG 22419
DE
Resultatopgørelse
- Annual
- Quarterly
Folk ser også
Leder du stadig efter en mægler, du kan stole på?
Deltag sammen med 500.000+ handlende over hele verden, der valgte at handle hos Capital.com